Virus-like particles as vaccine adjuvants.
Virus-like particles (VLPs) consist of one or more viral coat proteins that assemble into particles. They can be taken up by antigen presenting cells (APC), peptides derived from them are presented on MHC class I molecules at the cell surface, and thereby prime a CD8+ T cell response, either against...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2001
|